Saturday, June 23, 2012
|14:00 - 15:30 || |
EW1 - EMPAG Workshop
EW1 Parents & Children in Families with Huntington's Disease
L. B. Van der Meer1, A. Blom2;
1Leiden University Medical Center, Leiden, Netherlands, 2Academic Medical Center, Amsterdam, Netherlands.
|16:00 - 16:30|
Opening: joint with ESHG Welcome addresses
|16:30 - 18:00|
EPL1 - EMPAG Plenary Session: Decision making and outcome in genetic counselling
EPL1.1 Priority setting in genetic testing: a pilot discrete choice experiment
F. Severin1, J. Schmidtke2, A. Mühlbacher3, W. Rogowski1;
1Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany, 2Hannover Medical School, Institute for Human Genetics, Hanover, Germany, 3Hochschule Neubrandenburg, University of Applied Science, Neubrandenburg, Germany.
EPL1.2 First Trimester Screening, it's not a routine test An education module for General Practitioners to help women to make an informed choice
K. K. Barlow-Stewart1,2, K. Dunlop2;
1University of Sydney, Sydney, Australia, 2Centre for Genetics Education, Sydney, Australia.
EPL1.3 What do pregnant women and their partner know about Down Syndrome when they decide to undergo prenatal diagnosis?
C. Ingvoldstad1, P. Lindgren2, G. AnnerÃ©n3, E. Ternby2, O. Axelsson4;
1Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden, 2Department of women´s and children´s health, Uppsala University, Uppsala, Sweden, 3Department of genetics and pathology, Uppsala University, Uppsala, Sweden, 4Department of women`s and children´s health, Uppsala University, Uppsala, Sweden.
EPL1.4 How do women make decisions about genetic carrier screening for fragile X syndrome? A qualitative study
A. G. Ames1,2, A. D. Archibald1, R. Duncan1, J. Emery3, S. A. Metcalfe1,2;
1Murdoch Childrens Research Institute, Melbourne, Australia, 2University of Melbourne, Parkville, Australia, 3The University of Western Australia, Crawley, Australia.
EPL1.5 Development and validation of a short family history screening tool for chronic disease prevention in primary care
F. M. Walter1,2, T. A. Prevost1,3, L. Birt1, N. Grehan1, K. Restarick1, H. C. Morris1, P. Rose4, S. Downing5, S. Sutton1, J. D. Emery2,1;
1University of Cambridge, Cambridge, United Kingdom, 2University of Western Australia, Perth, Australia, 3King's College London, London, United Kingdom, 4Oxford University, Oxford, United Kingdom, 5Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
EPL1.6 Measuring patient benefits from interventions in clinical genetics and genetic counselling services: Are we finally able to do this?
M. McAllister1, A. M. Wood2, G. Dunn2, K. Payne2, L. Davies2, D. Donnai3, R. MacLeod2, C. Todd2;
1Cardiff University, Cardiff, United Kingdom, 2University of Manchester, Manchester, United Kingdom, 3St Mary's Hospital, Manchester, United Kingdom.
|18:00 - 18:30||Coffee break|
|18.30 - 20:00|
EPL2 - EMPAG Plenary Session: Risk communication and predictive tesing in Europe
EPL2.1 Breast cancer risk communication by health care providers' in 4 European countries
C. Julian-Reynier1,2,3, A. Bouhnik1,2, G. Evans4, H. Harris5, C. van Asperen6, A. Tibben7,8, I. Nippert9;
1INSERM, UMR912 "Health Economy, Social Sciences & Medical Information Processing" (SESSTIM), Marseilles, France, 2Aix-Marseille UniversitÃ©, UMR-S912, Marseille, France, 3Institut Paoli-Calmettes, Marseille, France, 4Medical Genetics Research Group, Regional Genetics Service and National Molecular Genetics Reference Laboratory, Central Manchester Foundation Trust, St Mary's Hospital, Manchester, United Kingdom, 5GenEd Coordinating Centre, University of Manchester, Manchester, United Kingdom, 6Center for Human and Clinical Genetics, Department of Clinical Genetics, Leiden University Medical Center (LUMC), Leiden, Netherlands, 7Centre of Human and Clinical Genetics, Leiden University Medical Centre (LUMC), Leiden, Netherlands, 8Department of Clinical Genetics, Erasmus MC, Rotterdam, Netherlands, 9Women's Health Research, Münster Medical School, Münster, Germany.
EPL2.2 International variation in physicians' attitudes towards prophylactic mastectomy - comparison between the UK, France, Germany, and the Netherlands
M. den Heijer1, C. J. van Asperen2, H. Harris3, I. Nippert4, C. Julian-Reynier5, G. Evans6, A. Tibben2;
1Department of Clinical Genetics, Erasmus MC, Rotterdam, Netherlands, 2Department of Clinical Genetics, Leiden University Medical Centre, Leiden, Netherlands, 3GenEd Coordinating Centre, University of Manchester, Manchester, United Kingdom, 4Women's Health Research, Munster Medical School, Munster, Germany, 5U912, INSERM, IRD, Institut Paoli-Calmettes, Aix-Marseille Universite, Marseille, France, 6Medical Genetics Research Group and Regional Genetics Services, St. Mary's Hospital, Manchester, United Kingdom.
EPL2.3 “Life at risk”: Negotiating identities on healthy carriers of a genetic alteration predisposing to cancer.
E. Sumalla1, V. Castejon1, C. Ochoa2, Y. Valverde1, A. Solanes3, G. Capella1, I. Blanco1,4;
1Genetic Counseling Unit. Hereditary Cancer Program., L'Hospitalet, Spain, 2Psycho-Oncology Unit, L'Hospitalet, Spain, 3Genetic Counseling Unit. Hereditary Cancer Program., Badalona, Spain, 4Genetic Counseling Unit, Hereditary Cancer Program, Badalona, Spain.
EPL2.4 Women's experiences of familial ovarian cancer screening: A qualitative study
K. J. Lifford1, A. Clements2, L. Fraser3, D. Lancastle4, K. Brain1;
1Institute of Primary Care and Public Health, School of Medicine, Cardiff University, Cardiff, United Kingdom, 2Department of Primary Health Care Sciences, University of Oxford, Oxford, United Kingdom, 3Gynaecological Oncology, University College London Institute for Women's Health, London, United Kingdom, 4Department of Humanities and Social Sciences, University of Glamorgan, Pontypridd, United Kingdom.
EPL2.5 What counts as successful in genetic counselling for presymptomatic testing in late onset disorders? The consultands' perspective.
L. GuimarÃ£es1, J. Sequeiros2,1, H. Skirton3, M. Paneque Herrera2,1;
1ICBAS-Universidade do Porto, Porto, Portugal, 2CGPP-IBMC, Porto, Portugal, 3School of Nursing and Midwifery, University of Plymouth, Plymouth, United Kingdom.
EPL2.6 Impact of predictive genetic testing for Huntington's disease (HD), Familial Cardiomyopathy (FCM) and Hereditary Breast and Ovarian Cancer (HBOC) in young people
R. M. MacLeod1, A. Beach2, S. Henriques2, J. Knopp2, K. Nelson2, L. Kerzin-Storrar1;
1Genetic Medicine, Manchester Academic Health Science Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom, 2University of Manchester, Manchester, United Kingdom.
20:00 - 21:30
|Welcome Reception at the Nürnberg Convention Centre|
Sunday, June 24, 2012
|08:30 - 10:00 |
Educational Session ES4 - Applying family dynamics/therapy in genetic counselling (joint Educational Session with ESHG)
ES4.1 The Family's Experience of a Genetic Disorder, Suzan McDaniel, USA
ES4.2 Using systemic ideas in Genetic Counsellors' group supervision, Tom O'Neill, UK
|10:00 - 10:30||Coffee Break, Free Poster Viewing, Exhibition|
|10:30 - 11:30 |
Poster Viewing with Authors (odd poster numbers)
|11:30 - 13:15|
Lunch, Free Poster Viewing, Exhibition
|13:15 - 14:45|
EPL3 - EMPAG Plenary Session: Reproductive issues and newborn screening
EPL3.1 The impact of NIPD on clinical practice: what do prenatal care providers need to know?
M. Bishop, J. Haydon, D. Latham, J. Tennant, P. Farndon;
NHS National Genetics Education and Development Centre, Birmingham, United Kingdom.
EPL3.2 Non-invasive prenatal diagnosis for fetal sex determination - benefits and disadvantages from the service users' perspective
C. Lewis1, M. Hill2, H. Skirton3, L. Chitty4,2;
1Genetic Alliance UK, London, United Kingdom, 2Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, 3Faculty of Health, University of Plymouth, Plymouth, United Kingdom, 4Clinical and Molecular Genetics, UCL Institute of Child Health,, London, United Kingdom.
EPL3.3 Using discrete choice experiments to explore stakeholder preferences for non-invasive prenatal diagnosis compared to current invasive testing
M. Hill1,2, F. Forya2, J. Fisher3, S. Morris4,5, L. Chitty1,2;
1Clinical and Molecular Genetics, Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, 2Fetal Medicine Unit, University College London Hospitals NHS Foundation Trust, London, United Kingdom, 3Antenatal Results and Choices, London, United Kingdom, 4UCLH/UCL Comprehensive Biomedical Research Centre, London, United Kingdom, 5Research Department of Epidemiology and Public Health, University College London, London, United Kingdom.
EPL3.4 Ethical issues in the use of pronuclear and maternal spindle transfer to prevent mitochondrial disorders
Genetic Medicine, St Mary's Hospital, Manchester, United Kingdom.
EPL3.5 The impact of carrier results generated by newborn screening on the family
F. Ulph1, T. Cullinan2, N. Qureshi3, J. Kai3;
1University of Manchester, Manchester, United Kingdom, 2East Staffordshire Clinical Commissioning Group, Burton upon Trent, United Kingdom, 3University of Nottingham, Nottingham, United Kingdom.
EPL3.6 Divergent views on newborn and infant genetic screening: perspectives of parents of healthy children and relatives of children with genetic conditions causing developmental delay
S. A. Metcalfe1, A. D. Archibald2,3, A. Atkinson1, C. Hickerton2, S. Lawton1, B. McClaren2, S. Wong1;
1Murdoch Childrens Research Institute and Dept Paediatrics, University of Melbourne, Parkville, Vic, Australia, 2Murdoch Childrens Research Institute, Parkville, Vic, Australia, 3Genetic Health Services Victoria, Parkville, Vic, Australia.
|14:45 - 15:15||Fitness Break|
|15:15 - 16:45|
EW2 - EMPAG Workshop
EW2 Methodological guidelines for empirical validation of genetic counselling interventions
J. C. Rocha;
UnIPSa, ISCS-N, Gandra, Portugal.
|16:45 - 17:15||Coffee Break, Free Poster Viewing, Exhibition|
|17:15 - 18:45|
Concurrent Symposium S08. 25 Years Psychosocial research in Clinical Genetics: Making up the balance (joint Sympopsium with ESHG)
S08.1 Past, present and future of psychological research in genetics: a personal view and a focus on the impact of predictive testing, Gerry Evers-Kiebooms, Belgium
S08.2 Translation of psychosocial research findings into an evidence base for genetic counselling practice and training , lauren Kerzin-Storrar, United Kingdom
S08.3 Psychosocial issues in cancer genetics, Eveline Bleiker, The Netherlands
Monday, June 25, 2012
|08:30 - 10:00|
EPL4- EMPAG Plenary Session: Cancer genetic counselling
EPL4.1 Evaluation of the efficacy of two models of delivering information about treatment-focused genetic testing among young women newly diagnosed with breast cancer>
B. Rahman1,2, B. Meiser1,2, K. Watts1,2, M. Gleeson3,2, C. Saunders4, G. Mitchell5, K. Barlow-Stewart6, J. Kirk7, K. Tucker2;
1Psychosocial Research Group, Sydney, Australia, 2Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia, 3Hunter Genetics, NSW, Australia, 4Department of Surgery, University of Western Australia, WA, Australia, 5Peter MacCallum Cancer Centre, VIC, Australia, 6Centre for Genetics Education, Sydney, Australia, 7Westmead Institute for Cancer Research, Sydney, Australia.
EPL4.2 Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm
K. E. Brain1, K. J. Lifford1, L. Fraser2, A. N. Rosenthal2,3, M. T. Rogers4, D. Lancastle5, C. Phelps6, E. K. Watson7, A. Clements8, R. Iredale4, I. Jacobs9, U. Menon2;
1Institute of Primary Care and Public Health, School of Medicine, Cardiff University, Cardiff, United Kingdom, 2Gynaecological Oncology, University College London Institute for Women's Health, London, United Kingdom, 3Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University London, London, United Kingdom, 4School of Medicine, Cardiff University, Cardiff, United Kingdom, 5Department of Humanities and Social Sciences, University of Glamorgan, Pontypridd, United Kingdom, 6School of Psychology & Counselling, Swansea Metropolitan University, Swansea, United Kingdom, 7School of Health and Social Care, Oxford Brookes University, Oxford, United Kingdom, 8Department of Primary Health Care Sciences, University of Oxford, Oxford, United Kingdom, 9Faculty of Medical and Health Sciences, University of Manchester, Manchester, United Kingdom.
EPL4.3 Are illness perceptions a useful predictor of emotional distress over time in individuals undergoing cancer genetic risk assessment?
C. Phelps1, P. Bennett2, A. Murray3, K. Brain4;
1Swansea Metropolitan University, Swansea, United Kingdom, 2Swansea University, Swansea, United Kingdom, 3Cancer Genetics Service for Wales, Cardiff, United Kingdom, 4Institute of Medical Genetics, Cardiff University, Cardiff, United Kingdom.
EPL4.4 The underestimated impact of prophylactic mastectomy
J. P. Gopie1, R. Timman2, M. T. Hilhorst2, M. A. M. Mureau2, A. Tibben1,2;
1Leiden University Medical Center, Leiden, Netherlands, 2Erasmus University Medical Center, Rotterdam, Netherlands.
EPL4.5 The impact of risk-reducing hysterectomy and/or oophorectomy in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome
R. Moldovan1,2, S. Keating1,3, T. Clancy1;
1Genetic Medicine, University of Manchester, Manchester, United Kingdom, 2Department of Clinical Psychology and Psychotherapy, Babes-Bolyai University, Cluj-Napoca, Romania, 3Genetic Health Service, Auckland, New Zealand.
EPL4.6 The use of an electronic genealogy database in cancer genetic counseling in Iceland
V. Stefansdottir1, O. T. Johannsson2, H. Skirton3, L. Tryggvadottir4, H. Tulinius5, C. Chapman6, J. J. Jonsson7,8;
1Dept. of Genetics and Molecular Medicine, Landspitali, Reykjavik, Iceland, 2Dept. of Medical Oncology, Landspitali - The National University Hospital, Reykjavik, Iceland, 3Faculty of Health, Education and Society, Plymouth Univ., Plymouth, United Kingdom, 4Icelandic Cancer Registry, Reykjavik, Iceland, 5The Genetical Committee of the University of Iceland, Reykjavik, Iceland, 6West Midlands Regional Genetics Unit, Birmingham Women Hospital NHS Trust, Birmingham, United Kingdom, 7Landspitali - The National University Hospital, Reykjavik, Iceland, 8Department of Medicine, University of Iceland, Reykjavik, Iceland.
|10:00 - 10:30||Coffee break|
|10:30 - 11:30|
Poster Viewing with Authors (even poster numbers)
|11:30 - 13:15|| Lunch, Free Poster Viewing, Exhibition|
|13:15 - 14:45 |
EPL5 EMPAG Plenary Session: Emerging issues in genetic counselling
EPL5.1 Self- and Other-Oriented Reassurance in Telegenetic Counselling
S. Sarangi1, O. Zayts2;
1Cardiff University, Cardiff, United Kingdom, 2The University of Hong Kong, Hong Kong, China.
EPL5.2 Profile of genetic counsellor and genetic nurse practice in Europe
H. Skirton1, C. Cordier2, D. Lambert3, U. Hosterey-Ugander4, M. Voelckel5;
1Faculty of Health, Education and Society, Taunton, United Kingdom, 2University Hospital of Strasbourg, Strasbourg, France, 3Our Lady's Children's Hospital, Crumlin, Ireland, 4Sahlgrenska University Hospital, Gothenburg, Sweden, 5La Timone Hospital, Marseille, France.
EPL5.3 Rational and reasonable: requests for genetic testing of children
I. Holme, G. Crawford, A. Fenwick, A. Lucassen;
Southampton University, Southampton, United Kingdom.
EPL5.4 Assessing the effects of genetic counseling for people with serious mental illness: findings of the first randomized controlled trial
J. Austin1, C. Hippman1, A. Inglis1, A. Ringrose1, J. Cheek2, W. Honer1;
1University of British Columbia, Vancouver, BC, Canada, 2Vancouver Island Health Authority, Victoria, BC, Canada.
EPL5.5 Assessing wellbeing in women caring for children with Duchenne or Becker muscular dystrophy
H. L. Peay1,2, K. Kinnett1,3, B. Meiser4, A. Tibben2;
1Parent Project Muscular Dystrophy, Richmond, VA, United States, 2Leiden University Medical Center, Leiden, Netherlands, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States, 4Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
EPL5.6 Interventions and Outcomes for Inherited Retinal Dystrophy: A Qualitative Examination
R. Combs1, G. Hall2, M. McAllister3, K. Payne1, S. Downes4, J. Lowndes4, A. Moore5, S. Devery5, G. Wright5, S. Ramsden2, G. Black1;
1University of Manchester, Manchester, United Kingdom, 2Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom, 3Cardiff University, Cardiff, United Kingdom, 4Oxford Eye Hospital, Oxford, United Kingdom, 5Moorfields Eye Hospital, London, United Kingdom.
| 14:45 - 15:15||Fitness break|
|15:15 - 16:45|
Workshop WS13: Dilemmas in HD practice (joint Workshop with ESHG) (Tara Clancy, Rhona Macleod, Aad Tibben)
|16:45 - 17:15||Coffee Break|
|17:15 - 18:45|
Concurrent Symposium S16. Debate on Informed Consent in New Technologies (joint Symposium with ESHG)
S16.1 How to inform individuals of the relevance of incidental WGA findings?, Christian Netzer, Germany
S16.2 Biobanks: should individuals be informed of findings from biobank studies? Can informed consent be realized?, Anne Cambon-Thomsen, France
S16.3 Informed consent in non-invasive prenatal diagnosis, Zuzana Deans, United Kingdom
Tuesday, June 26, 2012
|09:00 - 10:30|
EPL6 - EMPAG Plenary Session: Communicating genetic information
EPL6.1 Providing written information as an aid in Genetic Counseling - dispensable or helpful?
C. Walter1,2, H. Berth3, F. Kreuz3, K. Schenck-Kaiser4, H. Schindelhauer-Deutscher1;
1Association Psychosocial Aspects of Human Genetics, Homburg/Saar, Germany, 2Institute of Human Genetics, Freiburg, Germany, 3Association Psychosocial Aspects of Human Genetics, Dresden, Germany, 4Association Psychosocial Aspects of Human Genetics, Freiburg, Germany.
EPL6.2 Communicating familial breast cancer risks: risk presentation formats and women's preferences
L. Henneman1,2, C. J. Van Asperen3, J. C. Oosterwijk4, F. H. Menko1, L. Claassen1,2, C. F. Ockhuysen-Vermey1,2, D. R. M. Timmermans1,2;
1VU University Medical Center, Amsterdam, Netherlands, 2EMGO Institute for Health and Care Research, Amsterdam, Netherlands, 3Leiden University Medical Center, Leiden, Netherlands, 4University Medical Center, Groningen University, Groningen, Netherlands.
EPL6.3 The Signal-Trial: Evaluation of a Checklist to Improve Communication about Psychosocial Problems in Cancer Genetics
W. Eijzenga1, N. K. A. Aaronson1, D. E. E. Hahn1, I. Kluijt1, G. N. Sidharta1, M. G. E. M. Ausems2, E. M. A. Bleiker1;
1The Netherlands Cancer Institute, Amsterdam, Netherlands, 2University Medical Center Utrecht, Utrecht, Netherlands.
EPL6.4 Disclosure of information within french families with BRCA mutation
C. Rambaud1, A. Birot1, A. Damette2, C. Populaire2, A. Cueff3, F. Coron1, C. Loustalot4, C. Cassini1, P. Fumoleau3, J. SautiÃ¨re5, X. Pivot6, F. Debomy1, S. Gauthier1, M. Collonge-Rame2, L. Faivre1;
1Centre de gÃ©nÃ©tique, Hopital d'Enfants, Dijon, France, 2Service d'oncogÃ©nÃ©tique, BesanÃ§on, France, 3Service d'oncologie, Centre G.F. Leclerc, Dijon, France, 4Service d'oncogÃ©nÃ©tique, Centre G.F. Leclerc, Dijon, France, 5Service de gynÃ©cologie, BesanÃ§on, France, 6Service d'oncologie, HÃ´pital Minjoz, BesanÃ§on, France.
EPL6.5 The impact on self and family of receiving genetic test results following participation in the Australian Ovarian Cancer Study (AOCS)
N. Hallowell1, K. Alsop2, M. Gleeson3, D. Bowtell2, G. Mitchell2, .. The Australian Ovarian Cancer Study Group4;
1PHG Foundation, Cambridge, United Kingdom, 2Peter MacCallum Cancer Centre, Melbourne, Australia, 3Hunter Genetics, Newcastle NSW, Australia, 4Westmead Institute for Cancer Research, University of Sydney and Millennium Institute, and Departments of Gynaecological Oncology, Westmead Hospital, NSW, Queensland Institute for Medical Research,, Australia.
EPL6.6 Enhancing family communication about genetics: ethical and professional challenges
C. Gaff1,2, J. Hodgson3,4;
1Department of Medicine, The University of Melbourne, Melbourne, Australia, 2Victorian Comprehensive Cancer Centre, Melbourne, Australia, 3Murdoch Childrens Research Institute, Melbourne, Australia, 4Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
|10:30 - 11:00||Coffee Break, Free Poster Viewing, Exhibition|
11:00 - 12:30
EPL7 - EMPAG Closing Plenary Session
EPL7.1 Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeqTM study
B. B. Biesecker1, F. M. Facio1, H. Eidem1, T. Fisher1, S. Brooks1, A. Linn1, K. A. Kaphingst2, L. G. Biesecker1;
1National Human Genome Research Institute, Bethesda, MD, United States, 2Washington University, St. Louis, MO, United States.
EPL7.2 Introducing high-throughput seqencing in the clinical setting - but what will patients think ?
A. Soulier, S. Leonard, S. Julia, A. Cambon-Thomsen;
UMR 1027, Inserm, UniversitÃ© de Toulouse - UniversitÃ© Paul Sabatier -Toulouse III, EpidÃ©miologie et analyses en santÃ© publique : risques, maladies chroniques et handicaps, Toulouse, France.
EPL7.3 Rapid genetic testing for BRCA1/2 genes: How could oncogenetic counseling deal with an urgent choice?
E. Razzaboni1, L. Cortesi1, G. Tazzioli2, M. Pignatti3, A. Baccarani3, A. Andreotti2, E. De Matteis1, V. Medici1, M. Federico1;
1Department of Oncology, Haematology and Respiratory Disease, Modena, Italy, 2Department of General Surgery and Surgical Specialities, Modena, Italy, 3Department of Plastic and Reconstructive Surgery, Modena, Italy.
EPL7.4 The impact of diagnostic developments in prenatal diagnosis; a psychological challenge
S. Riedijk, G. Oudesluijs, J. Hunfeld, S. le Sage, R. Galjaard, A. Tibben;
Erasmus Medical Center, Rotterdam, Netherlands.
EPL7.5 Close parental relatedness identified by SNP microarray - challenges for genetic counselling
R. Forbes1, T. Burgess2, D. Amor1,3,4, Z. Stark1;
1Victorian Clinical Genetics Service, Royal Children's Hospital, Melbourne, Victoria, Australia, 2Victorian Clinical Genetics Service Pathology, Cytogenetics,Royal Children's Hospital, Melbourne, Victoria, Australia, 3Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Australia, 4University of Melbourne, Department of Paediatrics, Melbourne, Victoria, Australia.
EPL7.6 Criteria for responsible introduction of genome-based-technologies and information into public health care
H. C. Howard1, E. Swinnen2, K. Douw3, H. Vondeling3, J. Cassiman2, A. Cambon-Thomsen4, P. Borry2;
1University of Basel, Basel, Switzerland, 2KULeuven, Leuven, Belgium, 3University of Twente, Enschede, Netherlands, 4INSERM, UniversitÃ© de Toulouse 3 Paul Sabatier, Toulouse, France.
Awards & Closing remarks
|Close of meeting|